名称 | Myelofibrosis predicts deep molecular response 4.5 in chronic myeloid leukaemia patients initially treated with imatinib: An extensive, multicenter and retrospective study to develop a prognostic model |
作者 | Tian Zeng1,2,3; Xiudi Yang1,2,3; Yi Wang3,4; Dijiong Wu3,5; Weiying Feng3,6; Ying Lu3,7; Xiaoqiong Zhu2,3,8; Lirong Liu3,9; Mei Zhou3,10; Li Zhang3,11; Yanping Shao3,11; Honglan Qian3,12; Feng Zhu3,13; Yu Chen3,14; Dan Cao3,15; Li Huang3,16; Xiaoning Feng3,17; Lili Chen3,18; Gang Zhang3,19; Jing Le3,20; Weiguo Zhu3,21; Yongming Xia3,22; Yanxia Han3,23; Yongqing Jia3,24; Guoyan Tian3,25; Hui Zhou3,25; Linjuan Xu3,26; Xiufeng Yin3,27; Qinli Tang3,28; Yuefeng Zhang3,29; Guoli Yao3,29; Xianghua Lang3,30; Kaifeng Zhang3,31; Xiujie Zhou3,32; Junbin Guo3,33; Jinming Tu3,34; Jianzhi Zhao3,35; Gongqiang Wu3,36; Huiqi Zhang3,37; Xiao Wu3,38; Qiulian Luo3,39; Lihong Cao3,40; Binbin Chu3,41; Wei Jiang3,42; Haiying Wu3,43; Liansheng Huang3,44; Meiwei Hu3,45; Muqing He3,46; Jingjing Zhu1,2,3; Hongyan Tong1,2,3; Jie Jin1,2,3; Jian Huang1,2,3
|
发表期刊 | Clinical and translational medicine |
语种 | 英语 |
原始文献类型 | Letter |
资助项目 | Key R&D Program of Zhejiang[2022C03137];Zhejiang Medical Association Clinical Medical Research Special Fund Project[2022ZYC-D09] |
ISSN | 2001-1326 |
卷号 | 14 |
期号 | 11 |
DOI | 10.1002/ctm2.70101 |
收录类别 | PUBMED |
发布日期 | 2024-11 |
URL | 查看原文 |
PubMed ID | 39576229 |
引用统计 | |
文献类型 | 其他 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/221709 |
专题 | 附属第一医院 温州医科大学 附属第二医院_儿童血液科 其他_附属东阳医院(东阳市人民医院) 其他_温州医科大学附属衢州医院 |
作者单位 | 1.Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; 2.Zhejiang Clinical Medical Research Center of Hematology, Hangzhou, China.; 3.CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.; 4.Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China.; 5.Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.; 6.Department of Hematology, Shaoxing People's Hospital, Shaoxing, China.; 7.Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.; 8.Department of Hematology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, YiWu, China.; 9.Department of Hematology, The Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.; 10.Department of Hematology, Zhuji Affiliated Hospital of Shaoxing University, Shaoxing, China.; 11.Department of Hematology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Taizhou, China.; 12.Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; 13.Department of Hematology, Zhoushan Hospital, Zhejiang University School of Medicine, Zhoushan, China.; 14.Department of Hematology, College of Medicine, Lishui Hospital, Zhejiang University, Lishui, China.; 15.Department of Hematology, Huzhou Central Hospital, Huzhou, China.; 16.Department of Hematology, The Affiliated Jinhua Hospital of Wenzhou Medical University, Jinhua, China.; 17.Department of Hematology, Lishui People's Hospital, Lishui, China.; 18.Department of Hematology, The First People's Hospital of Taizhou, Taizhou, China.; 19.Department of Hematology, The First Hospital of Jiaxing, The Affiliated Hospital of Jiaxing University, Jiaxing, China.; 20.Department of Hematology, Ningbo Medical Center Lihuili Hospital, Ningbo, China.; 21.Department of Hematology, Shaoxing Second Hospital, Shaoxing, China.; 22.Department of Hematology, The Affiliated Yangming Hospital of Ningbo University, Yuyao People's Hospital of Zhejiang Province, Yuyao, China.; 23.Department of Hematology, The Second Hospital of Jiaxing, Jiaxing, China.; 24.Department of Hematology, Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.; 25.Department of Hematology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.; 26.Department of Hematology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.; 27.Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.; 28.Department of Hematology, The First People's Hospital of PingHu, PingHu, China.; 29.Department of Hematology, First People's Hospital of Linping District, Hangzhou, China.; 30.Department of Hematology, Yongkang First People's Hospital Affiliated to Hangzhou Medical College, Yongkang, China.; 31.Department of Hematology, Xinchang County People's Hospital, Xinchang, China.; 32.Department of Hematology, Haining People's Hospital, Haining, China.; 33.Department of Hematology, The First People's Hospital Of Wenling, Wenling, China.; 34.Department of Hematology, The People's Hospital of Longyou City, Longyou, China.; 35.Department of Hematology, Shaoxing Central Hospital, Shaoxing, China.; 36.Department of Hematology, Dongyang Hospital Affiliated to Wenzhou Medical University, Dongyang People's Hospital, Dongyang, China.; 37.Department of Hematology, The First People's Hospital of Huzhou, Huzhou, China.; 38.Department of Hematology, The Affiliated Hospital of Medical School, Ningbo University, Ningbo, China.; 39.Department of Hematology, Yiwu Central Hospital, Yiwu, China.; 40.Department of Hematology, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China.; 41.Department of Hematology, Oncology Ningbo Mingzhou Hospital, Ningbo, China.; 42.Department of Hematology, Shangyu People's Hospital of Shaoxing, Shaoxing, China.; 43.Department of Hematology, Tongde Hospital of Zhejiang Province, Hangzhou, China.; 44.Department of Hematology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.; 45.Department of Hematology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.; 46.Department of Hematology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. |
推荐引用方式 GB/T 7714 | Tian Zeng,Xiudi Yang,Yi Wang,et al. Myelofibrosis predicts deep molecular response 4.5 in chronic myeloid leukaemia patients initially treated with imatinib: An extensive, multicenter and retrospective study to develop a prognostic model. 2024. |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
查看访问统计 |
谷歌学术 |
谷歌学术中相似的文章 |
[Tian Zeng]的文章 |
[Xiudi Yang]的文章 |
[Yi Wang]的文章 |
百度学术 |
百度学术中相似的文章 |
[Tian Zeng]的文章 |
[Xiudi Yang]的文章 |
[Yi Wang]的文章 |
必应学术 |
必应学术中相似的文章 |
[Tian Zeng]的文章 |
[Xiudi Yang]的文章 |
[Yi Wang]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论